title: Antibiotic-free segregational plasmid stabilization in Escherichia coli owing to the knockout of triosephosphate isomerase (tpiA).
abstract: BACKGROUND
  Segregational stability of plasmids is of major concern for recombinant bacterial production strains. One of the best strategies to counteract plasmid loss is the use of auxotrophic mutants which are complemented with the lacking gene along with the product-relevant ones. However, these knockout mutants often show unwanted growth in complex standard media or no growth at all under uncomplemented conditions. This led to the choice of a gene for knockout that only connects two essential arms of an essential metabolic pathway - the glycolysis.
  
  
  RESULTS
  Triosephosphate isomerase was chosen because its knockout will have a tremendous effect on growth on glucose as well as on glycerol. On glycerol the effect is almost absolute whereas on glucose growth is still possible, but with considerably lower rate than usual. This feature is essential because it may render cloning easier. This enzymatic activity was successfully tested as an alternative to antibiotic-based plasmid selection. Expression of a model recombinant β-glucanase in continuous cultivation was possible with stable maintenance of the plasmid. In addition, the complementation of tpiA knockout strains by the corresponding plasmids and their growth characteristics were tested on a series of complex and synthetic media. The accumulation of methylglyoxal during the growth of tpiA-deficient strains was shown to be a possible cause for the growth disadvantage of these strains in comparison to the parent strain for the Keio Collection strain or the complemented knock-out strain.
  
  
  CONCLUSIONS
  Through the use of this new auxotrophic complementation system, antibiotic-free cloning and selection of recombinant plasmid were possible. Continuous cultivation and recombinant protein expression with high segregational stability over an extended time period was also demonstrated.
authors.forename: Ram Shankar
authors.initials: RS
authors.lastname: Velur Selvamani
authors.forename: Maurice
authors.initials: M
authors.lastname: Telaar
authors.affiliation: Faculty of Technology, Fermentation Engineering, Bielefeld University, D-33594 Bielefeld, Germany. karl.friehs@uni-bielefeld.de.
authors.forename: Karl
authors.initials: K
authors.lastname: Friehs
authors.forename: Erwin
authors.initials: E
authors.lastname: Flaschel
mesh_terms: D003001:Cloning, Molecular; D004926:Escherichia coli / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism*; D029968:Escherichia coli Proteins / Q000235:genetics* / Q000378:metabolism; D055786:Gene Knockout Techniques; D006026:Glycoside Hydrolases / Q000235:genetics / Q000378:metabolism; D010957:Plasmids / Q000235:genetics* / Q000378:metabolism*; D011765:Pyruvaldehyde / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D014305:Triose-Phosphate Isomerase / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism
chemical_list: D029968:Escherichia coli Proteins; D011994:Recombinant Proteins; D011765:Pyruvaldehyde; D006026:Glycoside Hydrolases; D014305:Triose-Phosphate Isomerase
references.citation: PLoS One. 2009 Oct 19;4(10):e7526
references.pmid: 19838305
references.citation: J Biotechnol. 2004 Jul 1;111(1):17-30
references.pmid: 15196766
references.citation: Bioprocess Biosyst Eng. 2009 Feb;32(2):149-58
references.pmid: 18481103
references.citation: Biotechniques. 2005 May;38(5):775-81
references.pmid: 15945374
references.citation: J Biol Chem. 2011 Jul 1;286(26):23150-9
references.pmid: 21550976
references.citation: Arch Microbiol. 1998 Oct;170(4):209-18
references.pmid: 9732434
references.citation: FEBS Lett. 1970 Dec 11;11(4):273-276
references.pmid: 11945504
references.citation: Mol Microbiol. 1998 Feb;27(3):553-62
references.pmid: 9489667
references.citation: Microb Cell Fact. 2013 Apr 25;12:39
references.pmid: 23617558
references.citation: J Bacteriol. 1997 Oct;179(20):6472-9
references.pmid: 9335298
references.citation: BMC Biotechnol. 2008 Aug 11;8:61
references.pmid: 18694482
references.citation: J Mol Microbiol Biotechnol. 2004;7(4):197-203
references.pmid: 15383717
references.citation: Vaccine. 2009 Oct 30;27(46):6454-9
references.pmid: 19559109
references.citation: Res Microbiol. 1993 Sep;144(7):565-74
references.pmid: 8310182
references.citation: Microb Cell Fact. 2009 Mar 24;8:17
references.pmid: 19317892
references.citation: Mol Syst Biol. 2006;2:2006.0008
references.pmid: 16738554
references.citation: Carlsberg Res Commun. 1989;54(2):41-54
references.pmid: 2673278
references.citation: Acta Biochim Pol. 2001;48(4):1003-23
references.pmid: 11995964
references.citation: J Gene Med. 2010 Apr;12(4):323-32
references.pmid: 20209487
references.citation: J Biotechnol. 2008 Mar 20;134(1-2):127-36
references.pmid: 18308411
references.citation: Bioprocess Biosyst Eng. 2007 Jul;30(4):251-9
references.pmid: 17351833
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D583-90
references.pmid: 21097882
references.citation: Adv Biochem Eng Biotechnol. 2004;86:47-82
references.pmid: 15088763
references.citation: Appl Environ Microbiol. 1998 Jan;64(1):82-7
references.pmid: 9435063